203 related articles for article (PubMed ID: 31297092)
1. The Status of Metabolic Control in Patients With Type 2 Diabetes Attending Dasman Diabetes Institute, Kuwait.
Qaddoumi M; Al-Khamis Y; Channanath A; Tuomilehto J; Badawi D
Front Endocrinol (Lausanne); 2019; 10():412. PubMed ID: 31297092
[No Abstract] [Full Text] [Related]
2. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam.
Kamuhabwa AR; Charles E
Drug Healthc Patient Saf; 2014; 6():155-65. PubMed ID: 25368533
[TBL] [Abstract][Full Text] [Related]
3. Achievement of guideline targets of glycemic and non-glycemic parameters in North Indian type 2 diabetes mellitus patients: A retrospective analysis.
Ashraf H; Faraz A; Ahmad J
Diabetes Metab Syndr; 2021; 15(1):425-431. PubMed ID: 33588199
[TBL] [Abstract][Full Text] [Related]
4. Audit of glycemic control in patients with type 1 diabetes referred to a pediatric clinic in a specialized center in Kuwait.
Al-Abdulrazzaq D; Al-Taiar A; Shaltout A; Davidsson L; Al-Kandari H
Diabetes Res Clin Pract; 2019 Oct; 156():107827. PubMed ID: 31449872
[TBL] [Abstract][Full Text] [Related]
5. Managing type 2 diabetes: going beyond glycemic control.
Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
7. The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabetic patients with sub-optimal metabolic control.
Mughal MA; Jan M; Maheri WM; Memon MY; Ali M
J Pak Med Assoc; 2000 Nov; 50(11):381-6. PubMed ID: 11126815
[TBL] [Abstract][Full Text] [Related]
8. Risk factors, knowledge and health status in diabetic patients.
Habib SS; Aslam M
Saudi Med J; 2003 Nov; 24(11):1219-24. PubMed ID: 14647557
[TBL] [Abstract][Full Text] [Related]
9. PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION AMONG TYPE 2 DIABETIC PATIENTS AT MOI TEACHING AND REFERRAL HOSPITAL, ELDORET, KENYA.
Ndege BW; Diero LO; Owiti MO; Anjichi G; Siika AM
East Afr Med J; 2014 Aug; 91(8):253-60. PubMed ID: 26862649
[TBL] [Abstract][Full Text] [Related]
10. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
[TBL] [Abstract][Full Text] [Related]
11. Diabetic Complications and Factors Affecting Glycemic Control Among Patients With Type II Diabetes Mellitus Attending the Chronic Illness Clinics at Tabuk, Saudi Arabia.
Ghabban SJ; Althobaiti B; Farouk IM; Al Hablany M; Ghabban A; Alghbban R; Harbi S; Albalawi AE
Cureus; 2020 Nov; 12(11):e11683. PubMed ID: 33391919
[TBL] [Abstract][Full Text] [Related]
12. Glycemic control, hypertension and chronic complications in type 2 diabetic subjects attending a tertiary care centre.
Basit A; Hydrie MZ; Hakeem R; Ahmedani MY; Waseem M
J Ayub Med Coll Abbottabad; 2005; 17(2):63-8. PubMed ID: 16092655
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
14. Non-achievement of clinical targets in patients with type 2 diabetes mellitus.
Eid M; Mafauzy M; Faridah AR
Med J Malaysia; 2004 Jun; 59(2):177-84. PubMed ID: 15559167
[TBL] [Abstract][Full Text] [Related]
15. Association of Diabetic Neuropathy with Duration of Type 2 Diabetes and Glycemic Control.
Nisar MU; Asad A; Waqas A; Ali N; Nisar A; Qayyum MA; Maryam H; Javaid M; Jamil M
Cureus; 2015 Aug; 7(8):e302. PubMed ID: 26430576
[TBL] [Abstract][Full Text] [Related]
16. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
